Positron emission tomography (PET) was used to investigate regions of the brain that are selectively affected during different phases of the normal menstrual cycle. A total of 10 healthy 18-29 year old female volunteers had PET measurements of brain glucose metabolism between days 5 and 9 of the follicular phase when plasma concentrations of oestradiol and progesterone were relatively low and between days 5 and 8 of the luteal phase when plasma concentrations of oestradiol and progesterone were relatively high. Automated algorithms were used to align the PET images in each individual, transform them into the coordinates of a brain atlas, control for variations in whole brain measurements and compute f-score maps of phaserelated differences in regional glucose metabolism. The mid-folh'cular phase was associated with significantly higher glucose metabolism in thalamic, prefrontal, temporoparietal and inferior temporal regions. The mid-luteal phase was associated with significantly higher glucose metabolism in superior temporal, anterior temporal, occipital, cerebellar, cingulate and anterior insular regions. While this study should be considered to be exploratory, it provides normative data for future studies and illustrates how PET can be used to help characterize relationships between phases of the female life cycle, temporally related disorders and local functions of the living human brain.
Introduction
Positron emission tomography (PET) is an imaging technique that provides information about biochemical and physiological processes. In the brain, PET can offer regional measurements of blood flow, glucose metabolism, oxygen metabolism, the oxygen extraction ratio, protein synthesis, acid-base chemistry, blood-brain barrier permeability to water, the activity of an increasing number of enzymes, the synaptic availability of an © European Society for Human Reproduction and Embryology increasing number of neurotransmitters and the characteristics of an increasing number of neuroreceptors (KuhJ, 1990; Reiman and Mintun, 1990; Moresco et al, 1995) Brain measurements of regional blood flow and glucose metabolism are markers of local neuronal activity, which can be used to investigate how the brain is involved in normal and pathological human behaviours (Raichle, 1987) . For instance, PET has been used to characterize regions of the brain that are involved in aspects of perception (e.g. Coghill etal., 1994) , motor control (e.g. Deiber et al, 1991) , attention (e.g Corbetta et al, 1990) , memory (e.g. Schacter et al, 1995) , language (e.g. Petersen et al, 1988) , emotion (e.g Reiman etal, 1993) and mental imagery (e.g. Kosslyn et al, 1993) , those that are involved in the development and treatment of psychiatric and neurological disorders (e.g. Buchsbaum et al, 1982; Reiman et al, 1984; Baxter et al., 1987a Baxter et al., , 1992 Early et al, 1987; Drevets et al, 1992; Minoshima et al., 1995; Reiman, 1996) , and those that are related to age (e.g. Loessner et al, 1995) and gender (Gur et al, 1995) .
While PET cannot be used to study pregnant women because of the possible risk of radiation exposure to the developing fetus, it promises to help characterize how the local functions of the living human brain are related to other phases of the female life cycle (e.g. different stages of the menstrual cycle, the post-partum period and menopause), gender differences, aspects of sexuality (e.g. sexual preference, interest, excitement and orgasm), hormonal interventions and some of the disorders to which they are related In this exploratory study, PET was used to investigate regions of the brain that are selectively affected during different phases of the normal menstrual cycle.
Materials and methods

Subjects
PET was used to study 10 healthy nght-handed female subjects between the ages of 18 and 29 years who reported a history of normal 28-30 day menstrual cycles and no missed menses in the previous 12 months, who denied a history of gynaecological problems, premenstrual dysphonc disorder, other psychiatric disorders, use of oral contraceptives within the previous 6 months or use of centrally acting medications within the previous month, and who had no evidence of anaemiaV olunteers were recruited using advertisements, provided their signed informed consent and were studied under guidelines approved by the Institutional Review Boards at Good Samaritan Regional Medical Center and Arizona State University, AZ, USA. They were initially screened using menstrual and medical histories, a structured psychiatric interview (Spitzer et al, 1990) , a neurological examination and a plasma haemoglobin concentration measurement The normality of the menstrual cycle prior to the first PET session was confirmed using a urinary luteinizing hormone (LH) detection kit (Ovuquick; Quidel, San Diego, CA, USA), serial plasma concentrations of oestradiol, progesterone, follicle-stimulating hormone (FSH) and LH, and a daily premenstrual dysphoric disorder symptom rating scale (Hurt et aL, 1992) Participants had a mean ± SD age of 24.9 ± 3.2 years, a mean ± SD cycle length of 28.2 ± 2.3 days, and a mean ± SD ovulation day of 15.0 ± 1.5.
Methods
Experimental design PET measurements of brain glucose metabolism, plasma hormone assays and emotion ratings were acquired in each subject 5-9 days after the onset of menses (l e. the mid-folhcular phase) when plasma concentrations of oestradiol and progesterone were relatively low and 5-8 days after the onset of ovulation (i.e. the mid-luteal phase) when plasma concentrations of oestradiol and progesterone were relatively high (Figure 1 ). (The ovulation date was defined as the day following the detection of urinary LH.) To address possible order effects, the sequence of scans was counterbalanced such that half of the subjects had PET scans during the follicular and luteal phases of their second studied cycle, while the other half had PET scans during the luteal phase of their second studied cycle and the follicular phase of their third cycle. To address potentially confounding arcadian effects, subjects had their follicular and luteal studies at the same time of day. Imaging Magnetic resonance imaging (MSI) was performed on a 1.5 Tesla Signa system (General Electric, Milwaukee, WL USA) just prior to the subject's first PET session. Sagittal and coronal images were acquired using a spin echo-pulse sequence to facilitate head positioning in the PET scanner. A volumetric image, consisting of 128 contiguous horizontal slices with voxel dimensions of 1.25X0.94X1.50 mm, was acquired using a radio-frequency spoiled volumetric gradient echo acquisition (SPGR) [relaxation time (TR) = 33 ms, echo time (TE) = 5 ms, a = 30°, number of excitations (NEX) = 1, field of view (FOV) = 24 cm and imaging matrix = 256X192].
PET images were acquired using a 951/31 ECAT scanner (Siemens, Knoxville, TN, USA) which simultaneously records data for 31 horizontal slices with an in-plane resolution of 5.8-7.7 mm full width at half-maximum (FWHM), an axial resolution of 5.0-7.1 mm FWHM, a centre-to-centre slice separation of 3.4 mm and an axial FOV of 10.8 cm. Preparation for each PET session included a fasting period of at least 4 h, the use of a fast-hardening foam mold for head immobilization during the scanning session and head repositioning between the MRI and two PET sessions, and the placement of a catheter in the right antecubital vein to permit radiotracer administration. Six subjects also had placement of a catheter in then-left brachial artery during each scanning session to permit frequent sampling of arterial plasma activity and glucose concentration following radiotracer administration. A 20 min transmission scan was performed using a retractable ring source of 68 Ge/ 68 Ga to help correct the subsequent emission images for radiation attenuation Immediately afterwards, an emission scan was performed using an i.v. bolus injection of 10 mCi [
18 F]fluorodeoxyglucose (FDG), a 30 min FDG uptake period and a 30 min scan as the subject lay quietly with her eyes closed and directed forward.
Each emission image was reconstructed using a back-projection method, attenuation correction and a 0.40 cycles/pixel Harming filter, resulting in an in-plane resolution of 9.5 mm FWHM. In the six subjects who provided arterial blood samples, the radioactivity data were transformed into units of glucose metabolism (mg glucose per minute per 100 g tissue) using an adaptation of the Sokoloff autoradiographic method (Phelps et aL, 1979; Hutchins et aL, 1984) ; whole-brain glucose metabolism was computed as the average meas-2800 urement from all intracerebral voxels (including the ventricles) inferior to a horizontal section through the falx and superior to a horizontal section through the mid-thalamus.
Rating scales and endocrine assays
The Spielberger State-Trait Anxiety Inventory (Spielberger, 1983) and the Hamilton Depression Rating Scale (Hamilton, 1960) were administered immediately prior to each PET session. Blood samples were drawn and centrifuged at the tune of each PET session to provide plasma ahquots, which were stored at -70°C until the time of the radioimmunoassay. Radioimmunoassay kits (ICN Biomedical Inc., Costa Mesa, CA, USA), 125 I labels and single antibody-coated tube kits were used to make duplicate measurements of plasma oestradiol and progesterone; radioimmunoassay kits, I25 I labels and double antibody-coated tube kits were used to make duplicate measurements of plasma LH and FSH. The average intra-assay variation was 6% and the mean interassay variation was 13%.
Data analysis
Paired, two-tailed r-tests were used to compare mid-luteal and midfollicular measurements of plasma hormone concentrations, subjective ratings and (in the six subjects who had quantitative measurements) whole-brain glucose metabolism.
Automated algorithms were used to align the non-quantitative PET images in each subject (Woods et aL, 1992) , co-register them with the subject's MRI (Woods et aL, 1993) , transform the co-registered unages mto the coordinates of a standard brain atlas (Talairach and Tournoux, 1988; Evans et aL, 1992) , control for variations m wholebrain measurements, compute r-score maps of the differences in regional glucose metabolism between the mid-follicular and midluteal phases, and identify the magnitude and location of the maximal differences (Worsley et at., 1992) . To reduce type I errors, a critical /-score of 2.58 (P < 0.005, uncorrected for multiple comparisons) was used to characterize brain regions with significantly higher glucose metabolism during each phase of the menstrual cycle.
Results
As expected, plasma concentrations of FSH were significantly higher during the mid-follicular phase, plasma concentrations of oestradiol and progesterone were significantly higher during the mid-luteal phase and there were no significant differences between mid-follicular and mid-luteal plasma concentrations of LH (Table I) .
As expected by our selection of individuals who did not have a history of premenstrual dysphoric disorder or other psychiatric disorders, the subjects had low scores on the Hamilton Depression Rating Scale and the Spielberger StateTrait Anxiety Inventory dunng the mid-follicular and midluteal phases; they had slightly lower Hamilton Depression scores during the mid-luteal phase, which could reflect minor differences in mood during these phases of the menstrual cycle or statistical type I errors (Table I) .
Although statistical power was limited by the small number of subjects who had quantitative measurements, there were no significant differences between mid-follicular and mid-luteal measurements of whole-brain glucose metabolism (mean ± SD = 7.24 ± 0.74 and 7.36 ± 1.02 mg/min/100 g respectively; P = not significant). The mid-follicular phase was associated with significantly higher glucose metabolism in thalamic, prefrontal, temporoparietal and inferior temporal regions ( Figure 2A and Table II ). The mid-luteal phase was associated fields, brain volume or their combination. These differences could be mediated through the combined actions of oestradiol, progesterone and their active metabolites on specific intracellular receptors, their modulatory effects on other endocrine and neurotransmitter systems (Ball et al, 1972; Wong et al, 1987; Clarke and Mazyani, 1990; Weiland and Wise, 1990, Toran-Allerand et al, 1992) or their effects on other processes. Considering the direct and indirect effects of reproductive hormones, the distribution of their metabolic effects will not necessarily parallel the distribution of oestradiol and progesterone receptors in the human brain. [Although their distribution in the human brain remains to be clarified, rodent studies suggest that reproductive hormone receptors may be expressed throughout the cerebral cortex (Simerly et al, 1990) and most highly in the hypothalamus, anterior pituitary, amygdala and hippocampus (Pfaff and Kemer, 1973; Hagihara et al., 1992; Moresco et al., 1995) .] The brain areas with higher glucose metabolism during the mid-follicular phase may be relevant to the understanding of gender differences in brain function, behaviour and behavioural disorders. Thalamic nuclei serve as relay stations to multiple cortical areas (Mesulam, 1986) , including each of those that appear to be differentially affected during different phases of the menstrual cycle (Unfortunately, limitations in spatial resolution prevent us from pinpointing the thalamic nuclei and related neural circuits which account for the differences in regional glucose metabolism.) The lateral prefrontal regions have been implicated in executive functions and working memory (Mesulam, 1986; Petrides et al., 1993) . PET studies suggest that these regions are preferentially affected in patients with major depressive disorder (Baxter et al, 1987a; Drevets et al, 1992) , which is more common in females (American Psychiatric Association, 1994); schizophrenia (Buchsbaum et al, 1982) , which appears to have a later age of onset and a better prognosis in females (American Psychiatric 2801 with significantly higher glucose metabolism in superior temporal, anterior temporal, occipital, cerebellar, cingulate and anterior insular regions ( Figure 2B and Table HI) .
Discussion
This study identifies brain regions that are selectively affected during different phases of the normal menstrual cycle. In particular, it identifies differences in regional glucose metabolism at those times associated with particularly large differences in the plasma concentrations of reproductive steroid hormones. The mid-follicular phase, when plasma concentrations of oestradiol and progesterone were relatively low, was associated with higher glucose metabolism in thalamic, prefrontal, temporoparietal and inferior temporal regions The mid-luteal phase, when plasma concentrations of oestradiol and progesterone were relatively high, was associated with higher glucose metabolism in superior temporal, anterior temporal, occipital, cerebellar, cingulate and anterior insular regions.
The differences in regional glucose metabolism could reflect phase-related alterations in the activity of terminal neuronal fields (Schwartz et al., 1979) , the density of terminal neuronal Association, 1994), and normal ageing (Loessner et ai, 1995) . The left temporoparietaJ region is a heteromodal sensory association area; it appears to participate in word recognition, object recognition and constructional tasks (Mesulam, 1986) , some of which appear t 0 be performed at different skill levels in males and females tHalpem, 1992). PET studies find that this region is progressively affected during the course of Alzheimer's disease (H er h (Talairach and Toumoux, 1988) such that x is the distance m mm to the left (L) or right (R) of midline, y is the distance anterior (+) or posterior to the anterior commissure, and z is the distance superior (+) or inferior to a horizontal plane through the anterior and posterior commissures Brodmann's areas refer to the cytoarcmtectural map of the human cortex most extensively used by clinicians and researchers to describe functional regions of the brain The map was first proposed by Brodmann to account for regional differences in the density of brain cells with particular sizes and shapes (Mesulam, 1986) Brodmann's areas were derived from the study of non-human species and are not distinguished by precise boundaries Still, they provide a standard format for describing the approximate location of functional regions of interest Reiman et al, 1996) , which appears to be more common in females than males (Katzman and Kawas, 1994) , especially in those females who do not receive oestrogen replacement therapy (Paganini-Hill and Henderson, 1994; Honjo et al, 1995) . The inferior temporal region is a higher-order visual association area that participates in the representation of visual objects and faces (Mesulam, 1986; Schacter et al, 1995) . The brain areas with higher glucose metabolism during the mid-luteal phase may also be relevant to the understanding of gender differences in brain function, behaviour and behavioural disorders. The occipital regions include primary visual cortex and visual association areas (Mesulam, 1986) ; these regions are enriched in benzodiazepine receptors (Innis et al., 1991) and may be preferentially affected in generalized anxiety disorder (Buchsbaum et al, 1987) , which appears to be more common in females (American Psychiatric Association, 1994). The right superior temporal region is an auditory association area (Mesulam, 1986 ); it appears to be associated with higher neuronal density but lower glucose metabolism in females (GUT et al, 1995; Witelson et al, 1995) . The anterior temporal region includes visual association and paralimbic areas which have been implicated in the evaluation of objects and faces, the emotional response to exteroceptive sensory stimuli, the regulation of autonomic tone and socialization skills including maternal bonding (Kling and Steklis, 1976; Mesulam, 1986) ; the region appears to be associated with lower glucose metabolism in females (Gur et al, 1995) . The cerebellum participates in motor coordination (Mesulam, 1986) , has been implicated in other cognitive functions (Leiner et al, 1986 ) and appears to have lower glucose metabolism in females (Gur et al, 1995) . The mid-cingulate region is a paralimbic area which has been implicated in the subjective experience of anxiety and other emotions and the perception of pain (Mesulam, 1986; Coghill et al, 1994; Lane et al, 1996) ; this region appears to be associated with higher glucose metabolism in females (Gur et al, 1995) . The anterior insular region is a paralimbic area which has been implicated in autonomic control (Mesulam, 1986) , the perception of temperature and pain (Coghill et al, 1994; Bushnell et al, 1995) , anxiety (Reiman, 1996) , panic (Reiman etal, 1989) and other internally generated negative emotions (Reiman et al., 1993; Lane et al, 1995) .
Based on recent PET studies conducted in our laboratory, we postulate that the anterior insular region participates in the emotional evaluation of potentially distressing interoceptive Figure 2 . Images of significant differences in regional glucose metabobsm during different phases of the normal menstrual cycle Brain regions with significantly higher glucose metabobsm durmg the mid-folbcular phase are shown in (A), brain regions with significantly higher measurements during the mid-luteal phase are shown in (B). In each case, images were generated using positron emission tomography and magnetic resonance imaging (MRI) data from 10 healthy female subjects, /-value maps (colour-coded images) are superimposed onto an average of the subjects' brain MRI's (grey-scale image), horizontal brain secuons correspond to the coordinates of a brain atlas (Talairach and Toumoux, 1988) , the number next to each section reflects the distance in mm superior (+) or inferior (-) to a horizontal plane between the anterior and posterior commissures; the right hemisphere in each section is on the reader's right; and red, yellow and green indicate P < 0.005, <0.01 and <0.05, uncorrected for multiple comparisons, respectively. The mid-follicular phase was associated with significantly higher measurements in bilateral thalamic (Th), bilateral prefrontal (PF), left temporoparietal (TP) and left inferior temporal (IT) regions (/ > 2.58, P < 0.005, uncorrected for multiple comparisons) The mid-luteal phase was associated with significantly higher measurements in the vicinity of bilateral occipital (Oc), left superior temporal (ST), right anterior temporal (AT), left cingulate (Ci) and anterior insular (AT) regions (/ > 2.58, P < 0.005, uncorrected for mukiple comparisons). The location and magnitude of maximal differences are shown in Tables II and ITJ sensory or cognitive stimuli (Reiman et al, 1993; Lane et al, 1995; Reiman, 1996) . While this study finds increased anterior insular glucose metabolism during the mid-luteal phase, we postulate that this region will be even more strongly activated during the late luteal phase when physical sensations are more apparent. We postulate that this region and additional prefrontal regions implicated in the depressive state (Baxter et al, 1987a; Drevets et al., 1992) are affected during the late luteal phase m individuals with premenstrual dysphoric disorder.
This study found no significant differences between the mid-follicular and mid-luteal phases in whole-brain glucose metabolism. However, it is limited in statistical power and unable to disentangle the combined effects of oestradiol and progesterone. An autoradiographic study of ovariectomized adult female rats found that oestradiol treatment led to a 20% increase in whole-brain glucose metabolism (Namba and Sokoloff, 1984) . Because oestradiol's major metabolite is known to inhibit the metabolism of catecholamines (Ball et al, 1972) , the investigators suggested that the increase in brain glucose metabolism might be attributable to increased catecholamine concentrations (Namba and Sokoloff, 1984) . To our knowledge, studies have not yet examined the combined effects of oestradiol and progesterone on this measurement. PET studies suggest that women who are between days 5 and 15 of their menstrual cycle (i.e. when their plasma concentrations of oestradiol are relatively high and those of progesterone relatively low) have almost 20% higher whole-brain glucose metabolism than men (Baxter et al, 1987b) . Together, these studies lead us to consider the possibility that oestradiol and progesterone have opposing effects on whole-brain glucose metabolism. If so, we would predict that whole-brain glucose metabolism is lower during the early to mid-follicular phase when plasma concentrations of both oestradiol and progesterone are relatively low, higher during the late follicular phase when plasma concentrations of oestradiol are relatively high and those of progesterone are relatively low, and lower during the mid-luteal phase when plasma concentrations of both oestradiol and progesterone are relatively high. In any case, we suggest that researchers consider the potentially important (and, in some cases, confounding) effects of menstrual phase on whole-brain and regional PET measurements This study illustrates PET's potential to study aspects of the female life cycle (e.g. the menstrual cycle), disorders that are temporally related to the female life cycle (e.g. premenstrual dysphoric disorder) and disorders that could be modulated by reproductive hormones (e.g. Alzheimer's disease). It also illustrates the need to consider the potentially important effects of menstrual phase on whole-brain and regional PET measurements.
At the same time, this study illustrates several limitations in the interpretation of PET studies. For instance, limitations in the spatial resolution of PET prevent us from ruling out the possibility of phase-related metabolic differences in other brain regions, such as the hypothalamus or pituitary; limitations in statistical power prevent us from concluding that seemingly unilateral differences in regional glucose metabolism reflect significant hemispheric asymmetries; and limitations in the nature of this naturalistic study prevent us from disentangling 2804 the combined effects of oestradiol and progesterone on regional or whole-brain measurements. Finally, findings from this study should be considered to be exploratory, serving to generate testable hypotheses about the brain regions, neurophysiological alterations and cognitive operations that might be affected during different phases of the menstrual cycle.
Other positron-emitting radiotracers have promise in the study of the female brain. [
15 O]Water can be used to make repeated measurements of regional cerebral blood flow during a single scanning (Raichle, 1987) ; because the same individual can serve as her own control, it is possible to characterize the regional and whole-brain effects of specific hormonal challenges, behavioural tasks and their interactions.
[
18 F]Fluoro-oestradiol appears to be suitable for the visualization and measurement of oestradiol receptor characteristics in the hypothalamus, anterior pituitary and breast tumours (Mintun et al, 1988; Moresco et al, 1995) (progesterone receptor ligands have not yet been developed or tested). Other radioligands can be used to investigate how neurotransmitter systems are affected during different phases of the menstrual cycle (Wong et al, 1987; Clarke and Mazyani, 1990) . PET studies of regional blood flow, glucose metabolism, neurotransmitter processes and neuroreceptor processes promise to provide new information about the brain regions, chemical processes and cognitive operations that are selectively related to gender, phases of the female and male life cycle, hormonal challenges and treatments, and the disorders to which they are at least partly related.
